BAKER BROS. ADVISORS LP Q1 2021 Filing
Filed May 17, 2021
Portfolio Value
$23.1T
Holdings
126
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (126 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SGENUSDSeagen Inc. | 47,270,759 | $6.6T | 28.46% | |
| 2 | ONCBeiGene, Ltd. | 11,668,897 | $4.1T | 17.61% | |
| 3 | INCYIncyte Corporation | 32,001,387 | $2.6T | 11.28% | |
| 4 | KODKodiak Sciences Inc. | 13,879,952 | $1.6T | 6.82% | |
| 5 | ACADACADIA Pharmaceuticals Inc. | 41,910,704 | $1.1T | 4.69% | |
| 6 | ALXNAlexion Pharmaceuticals, Inc. | 3,993,312 | $610.6B | 2.65% | |
| 7 | NVTA1EURInvitae Corporation | 15,749,182 | $601.8B | 2.61% | |
| 8 | BMRNBioMarin Pharmaceutical Inc. | 7,589,294 | $573.1B | 2.48% | |
| 9 | ASNDAscendis Pharma A/S | 3,540,270 | $456.3B | 1.98% | |
| 10 | PRLDPrelude Therapeutics Incorporated | 10,123,824 | $438.7B | 1.90% | |
| 11 | ABCLAbCellera Biologics Inc. | 10,450,180 | $354.9B | 1.54% | |
| 12 | ARGXargenx SE | 1,119,557 | $308.3B | 1.34% | |
| 13 | 1K0IGM Biosciences, Inc. | 3,156,102 | $242.0B | 1.05% | |
| 14 | MRTXEURMirati Therapeutics, Inc. | 1,409,784 | $241.5B | 1.05% | |
| 15 | MDGLMadrigal Pharmaceuticals, Inc. | 1,499,213 | $175.4B | 0.76% | |
| 16 | AMRNAmarin Corporation plc | 26,453,422 | $164.3B | 0.71% | |
| 17 | GBTUSDGlobal Blood Therapeutics, Inc. | 3,217,441 | $131.1B | 0.57% | |
| 18 | BCRXBioCryst Pharmaceuticals, Inc. | 12,710,818 | $129.3B | 0.56% | |
| 19 | IMCRImmunocore Holdings plc | 2,520,730 | $107.3B | 0.47% | |
| 20 | PACBPacific Biosciences of California, Inc. | 3,201,972 | $106.7B | 0.46% | |
| 21 | TILInstil Bio, Inc. | 3,893,700 | $97.7B | 0.42% | |
| 22 | —Talis Biomedical Corporation | 7,574,835 | $97.3B | 0.42% | |
| 23 | HRTXHeron Therapeutics, Inc. | 5,994,704 | $97.2B | 0.42% | |
| 24 | CERSCerus Corporation | 13,713,195 | $82.4B | 0.36% | |
| 25 | ALLKGUSDAllakos Inc. | 703,050 | $80.7B | 0.35% | |
| 26 | —DBV Technologies S.A. | 14,614,264 | $77.9B | 0.34% | |
| 27 | NRIXNurix Therapeutics, Inc. | 2,454,082 | $76.3B | 0.33% | |
| 28 | KYMRKymera Therapeutics, Inc. | 1,959,211 | $76.1B | 0.33% | |
| 29 | RYTMRhythm Pharmaceuticals, Inc. | 3,479,873 | $74.0B | 0.32% | |
| 30 | IM8NInsmed Incorporated | 2,156,001 | $73.4B | 0.32% | |
| 31 | APLSApellis Pharmaceuticals, Inc. | 1,674,004 | $71.8B | 0.31% | |
| 32 | NBIXNeurocrine Biosciences, Inc. | 676,975 | $65.8B | 0.29% | |
| 33 | KRYSKrystal Biotech, Inc. | 760,412 | $58.6B | 0.25% | |
| 34 | —Forma Therapeutics Holdings, Inc. | 2,024,876 | $56.7B | 0.25% | |
| 35 | HZNPHorizon Therapeutics Public Ltd Co | 599,110 | $55.1B | 0.24% | |
| 36 | BCELAtreca, Inc. | 3,532,760 | $54.2B | 0.23% | |
| 37 | —Zymeworks Inc. | 1,708,472 | $54.0B | 0.23% | |
| 38 | ADAPYAdaptimmune Therapeutics plc | 9,830,877 | $52.2B | 0.23% | |
| 39 | KNSAKiniksa Pharmaceuticals, Ltd. | 2,799,577 | $51.8B | 0.22% | |
| 40 | RAREUltragenyx Pharmaceutical Inc. | 444,444 | $50.6B | 0.22% | |
| 41 | —Neoleukin Therapeutics, Inc. | 3,821,740 | $47.0B | 0.20% | |
| 42 | IMTXImmatics N.V. | 3,992,756 | $44.8B | 0.19% | |
| 43 | DSGNDesign Therapeutics, Inc. | 1,436,636 | $43.0B | 0.19% | |
| 44 | 698Achilles Therapeutics plc | 2,591,366 | $42.9B | 0.19% | |
| 45 | MRUSMerus N.V. | 2,037,469 | $42.6B | 0.18% | |
| 46 | VSTMVerastem, Inc. | 17,019,294 | $42.0B | 0.18% | |
| 47 | BCABBioAtla, Inc. | 825,000 | $41.9B | 0.18% | |
| 48 | ALTAltimmune, Inc. | 2,758,518 | $39.0B | 0.17% | |
| 49 | FLGTFulgent Genetics, Inc. | 401,016 | $38.7B | 0.17% | |
| 50 | PTGXProtagonist Therapeutics, Inc. | 1,436,192 | $37.2B | 0.16% | |
| 51 | ALGSAligos Therapeutics, Inc. | 1,610,000 | $36.6B | 0.16% | |
| 52 | AXSMAxsome Therapeutics, Inc. | 628,414 | $35.6B | 0.15% | |
| 53 | ADCTADC Therapeutics SA | 1,418,107 | $34.6B | 0.15% | |
| 54 | CCXIEURChemoCentryx, Inc. | 656,710 | $33.6B | 0.15% | |
| 55 | OPTEYOpthea Limited | 3,308,705 | $31.7B | 0.14% | |
| 56 | AGLEUSDAeglea BioTherapeutics, Inc. | 3,410,106 | $27.0B | 0.12% | |
| 57 | NVV1Novavax, Inc. | 143,756 | $26.1B | 0.11% | |
| 58 | ALKSAlkermes plc | 1,228,170 | $22.9B | 0.10% | |
| 59 | MREOMereo BioPharma Group plc | 6,719,948 | $22.6B | 0.10% | |
| 60 | RETAEURReata Pharmaceuticals, Inc. | 223,976 | $22.3B | 0.10% | |
| 61 | OTICEUROtonomy, Inc. | 7,220,074 | $18.4B | 0.08% | |
| 62 | AUPHAurinia Pharmaceuticals Inc. | 1,410,064 | $18.3B | 0.08% | |
| 63 | EWTXEdgewise Therapeutics, Inc. | 500,000 | $16.3B | 0.07% | |
| 64 | XNCRXencor, Inc. | 369,370 | $15.9B | 0.07% | |
| 65 | —Invitae Corporation | 10,300,000 | $15.6B | 0.07% | |
| 66 | BMRN 0.599 08/01/24BioMarin Pharmaceutical Inc. | 15,000,000 | $15.3B | 0.07% | |
| 67 | —Athira Pharma, Inc. | 806,367 | $14.8B | 0.06% | |
| 68 | BDQMAlbireo Pharma, Inc. | 412,466 | $14.5B | 0.06% | |
| 69 | XENEXenon Pharmaceuticals Inc. | 751,639 | $13.5B | 0.06% | |
| 70 | MIRMMirum Pharmaceuticals, Inc. | 647,313 | $12.8B | 0.06% | |
| 71 | SRPT 1.5 11/15/24Sarepta Therapeutics, Inc. | 9,174,000 | $12.0B | 0.05% | |
| 72 | 290AChinook Therapeutics, Inc. | 748,693 | $11.6B | 0.05% | |
| 73 | SPRYSilverback Therapeutics, Inc. | 238,095 | $10.4B | 0.05% | |
| 74 | RVMDRevolution Medicines, Inc. | 222,222 | $10.2B | 0.04% | |
| 75 | CBAYUSDCymabay Therapeutics, Inc. | 2,170,464 | $9.9B | 0.04% | |
| 76 | —Genetron Holdings Limited | 455,306 | $9.8B | 0.04% | |
| 77 | HOOKGBPHOOKIPA Pharma Inc. | 700,481 | $9.4B | 0.04% | |
| 78 | CRNXCrinetics Pharmaceuticals, Inc. | 616,520 | $9.4B | 0.04% | |
| 79 | ANABAnaptysBio, Inc. | 427,179 | $9.2B | 0.04% | |
| 80 | OPHTEURIVERIC bio, Inc. | 1,406,037 | $8.7B | 0.04% | |
| 81 | NGMUSDNGM Biopharmaceuticals, Inc. | 291,801 | $8.5B | 0.04% | |
| 82 | KRTXKaruna Therapeutics, Inc. | 69,966 | $8.4B | 0.04% | |
| 83 | —Gamida Cell Ltd. | 1,037,226 | $8.4B | 0.04% | |
| 84 | ASMBAssembly Biosciences, Inc. | 1,541,418 | $7.1B | 0.03% | |
| 85 | CABACabaletta Bio, Inc. | 636,363 | $7.1B | 0.03% | |
| 86 | —bluebird bio, Inc. | 226,988 | $6.8B | 0.03% | |
| 87 | MGNXMacroGenics, Inc. | 200,679 | $6.4B | 0.03% | |
| 88 | BNRBurning Rock Biotech Limited | 209,131 | $5.6B | 0.02% | |
| 89 | —NexImmune, Inc. | 294,117 | $5.6B | 0.02% | |
| 90 | GBYSangamo Therapeutics, Inc. | 429,063 | $5.4B | 0.02% | |
| 91 | ORTXUSDOrchard Therapeutics plc | 734,431 | $5.3B | 0.02% | |
| 92 | —Syros Pharmaceuticals, Inc. | 690,167 | $5.2B | 0.02% | |
| 93 | 5E7Iteos Therapeutics, Inc. | 150,346 | $5.1B | 0.02% | |
| 94 | DNLIDenali Therapeutics Inc. | 88,738 | $5.1B | 0.02% | |
| 95 | ALECAlector, Inc. | 239,228 | $4.8B | 0.02% | |
| 96 | —Evofem Biosciences, Inc. | 2,697,110 | $4.7B | 0.02% | |
| 97 | REPLReplimune Group, Inc. | 153,512 | $4.7B | 0.02% | |
| 98 | TVTXTravere Therapeutics, Inc. | 186,915 | $4.7B | 0.02% | |
| 99 | SRPTSarepta Therapeutics, Inc. | 58,700 | $4.4B | 0.02% | |
| 100 | PASGPassage Bio, Inc. | 235,362 | $4.1B | 0.02% |
Page 1 of 2Next